A first-in-class orally available HBV cccDNAdestabilizer ccc_R08 achieved sustainable HBsAg and cccDNA reduction in the HBVcircle mouse model | ||
| ||
| Reported by Jules Levin EASL 2019 Vienna April 1Li Wang, 1QihuiZhu, 1Jing Zeng,1 ZhipengYan,1Song Feng, 2John A. T. Young, and 1Lu Gao1Roche Innovation Centre Shanghai, Shanghai, China; 2. Roche Innovation Centre Basel, Basel, Switzerland | |
|
欢迎光临 肝胆相照论坛 (http://hbvhbv.info/forum/) | Powered by Discuz! X1.5 |